NFKB1 and colitis: Existing literature has reviewed that the anti-inflammatory effects of some drugs against DSS-induced colitis models are via the inhibition of NF-κB signaling pathway (Cheon et al., 2006; Zhou et al., 2017; Zhu et al., 2019).